Example: Heart Attack
Search clinical trials for: Dose decrease
Total 7779 results
-
NCT01690299CompletedPhase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque PsoriasisPsoriasis | Psoriatic Arthritis
-
NCT00863356Completed
-
NCT06431685RecruitingNSCLC | PD-1 Inhibitor | Leptomeningeal Metastasis | Low Dose Radiotherapy
-
NCT04311502Terminated
-
NCT01523977CompletedEverolimus With Multiagent Re-Induction Chemotherapy in Pediatric Patients With ALL (CRAD001NUS175T)Acute Lymphoblastic Leukemia
-
NCT01165541Completed
-
NCT02676622WithdrawnCrohn's Disease
-
NCT02731846Withdrawn
-
-
NCT01004705Terminated
-
NCT01659476Completed
-
NCT02005783CompletedFebrile Neutropenia | Grade 3/4 Neutropenia
-
NCT01511718Completed
-
NCT06737380RecruitingSystemic Lupus Erythematosus | SLE | Systemic Lupus Erythematosus (SLE) | Lupus | Systemic Lupus Erthematosus
-
NCT06128213Not yet recruitingUrinary Tract Infections | Pyelonephritis
-
NCT05941741RecruitingNasopharyngeal Carcinoma | Chemotherapy | Radiotherapy | Immune Checkpoint Inhibitor
-
-
NCT05384821Recruiting
-
NCT05027945RecruitingHematopoietic Stem Cell Transplantation | Immunodeficiency
-
NCT01804634RecruitingRefractory and/or Relapsed Metastatic Solid Tumors
-
NCT03678350CompletedMalignant Mesothelioma | Non-Small Cell Lung Carcinoma | Pleural Disorder
-
NCT04391049Active, not recruitingClinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Unresectable Gastroesophageal Junction Adenocarcinoma | Postneoadjuvant Therapy Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIA Gastroesophageal Junction Adenocarcinoma AJCC v8 | Postneoadjuvant Therapy Stage IIIB Gastroesophageal Junction Adenocarcinoma AJCC v8 | Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | Clinical Stage IIA Esophageal Adenocarcinoma AJCC v8 | Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | Pathologic Stage II Esophageal Adenocarcinoma AJCC v8 | Pathologic Stage IIA Esophageal Adenocarcinoma AJCC v8
-
NCT04951986Active, not recruitingHIV | Disseminated Tuberculosis
-
NCT06200545CompletedHIV Infection | Sexually Transmitted Infections | Pre-exposure Prophylaxis | Systems Navigation
-
NCT04508725CompletedKidney Cancer | Renal Cell Carcinoma | Metastatic Renal Cell Carcinoma
-
NCT04731467CompletedMelanoma | Pancreatic Cancer | Ovarian Cancer | Solid Tumor | Non Small Cell Lung Cancer | Colorectal Adenocarcinoma | Papillary Thyroid Cancer
-
NCT06348888CompletedHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 Mutation
-
-
NCT01951885CompletedAcute Myeloid Leukemia | Multiple Myeloma | Acute Lymphoblastic Leukemia | Chronic Lymphocytic Leukemia | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Chronic Myelogenous Leukemia | Myeloproliferative Neoplasm | Acute Biphenotypic Leukemia | Hodgkins Disease
-
NCT01062555Completed
-
NCT02483715CompletedHelicobacter Pylori Infection
-
NCT01732458CompletedPost-operative Nausea | Post-operative Vomiting
-
NCT01267734Unknown
-
NCT00323258Completed
-
NCT01052987Completed
-
NCT07060404Not yet recruitingDrug Pharmacokinetics in Healthy Volunteers
-
NCT03516617RecruitingChronic Lymphocytic Leukemia | Small Lymphocytic Lymphoma
-
NCT02680561Completed
-
NCT02519023Completed
-
NCT02071615Completed
-
NCT01172912UnknownTesticular Germ Cell Tumor | Brain and Central Nervous System Tumors | Extragonadal Germ Cell Tumor